Heart Failure and Cardiomyopathy Flashcards
What is heart failure?
The inability of the heart to properly fill or empty the ventricle
What usually causes heart failure?
CAD Cardiomyopathy Valve abnormalities (esp mitral and aortic) HTN Pericardial diseases Pulmonary HTN
Forms of ventricular dysfunction
Systolic and diastolic HF
Acute and chronic HF
Left and right sided HF
Low output or high output HF
Adaptive responses to HF
In the failing heart, these mechanisms are initiated to help improve CO:
Frank-Starling Relationship
SNS activation
Alterations in contractility, HR, and afterload
Humoral responses
When these mechanisms become maladaptive, it leads to myocardial remodeling.
What is myocardial remodeling?
Changes in size, shape, structure and physiology of the heart after injury to the myocardium
Initially, the body tries to compensate for HF in this manner
Activation of the SNS
Why does the body activate the SNS in HF?
It’s all about maintaining BP and CO**
1) Arteriolar constriction
- Maintains BP (increases SVR) despite decrease in CO
- Redirects blood flow to coronary and cerebral systems (shunt to important systems!)
2) Venous constriction
- Increase preload
- Attempt to increase CO via frank starling
3) RAAS
- Activated d/t decrease in RBF from shunting to important organs
- Causes increase in blood volume and ultimately CO
4) HR is increased (trying to increase CO)
Eventually this system will poop out because the increase in SVR increases workload
Patho of HF
Pressure overload- aortic stenosis, HTN
Volume overload – mitral or aortic regurgitation
Myocardial ischemia/infarction
Myocardial inflammatory disease
Restricted diastolic filling – constrictive pericarditis, restrictive myocarditis
Other adaptive mechanisms to increase CO
Increase in contraction velocity Reduction in afterload Increase in HR Release of BNP - Function is to decrease SVR and cause natriuresis
Myocardial remodeling that can occur
Hypertrophy
Dilation and wall thinning
Increased interstitial collagen deposition
Fibrosis and scar formation
Remodeling leads to increased O2 requirements (more at risk for ischemia)
S/S of HF
Dyspnea - Orthopnea/ orthopneic cough - Paroxysmal noctural dyspnea Fatigue Weakness at rest Tachycardia Oliguria Edema Atrial fibrillation due to dilation Tachypnea Lung Rales S3 gallop Hypotension JVD
Diagnosis of HF
CXR
Cardiac Echo
Elevated levels B-type natriuretic peptide
MRI
Management of HF
ACE Inhibitors/ ARBs
- Decrease afterload by interfering with RAAS to cause peripheral vasodilation
Aldosterone antagonists
- Aldosterone production is increased in HF d/t activation of the RAAS. Causes Na+ retention and K+ excretion.
Diuretics
- Decrease preload (thiazide and loop)
Digoxin
- Increases contractility and treats a-fib
Inotropes
- Increase contractility (dobutamine and milrinone)
Beta blockers
- Inhibit the SNS. Slow HR and lowers BP. Shown to reverse remodeling.
Vasodilator therapy
- Decreases afterload (hydralazine and isosorbide)
Biventricular pacing
- improves ventricular function and reverses remodeling
Nesiritide
- Synthetic BNP. Decreases preload by stimulating natriuresis, and decreases afterload via vasodilation
Assist devices
- IABP
Transplant
The presence of __ is the single most important risk factor for predicting perioperative cardiac morbidity and mortality
HF
Patho of HF in a nutshell
Decreased contractility
Ventricle is dilated to increase contractility from stretched muscle fibers
Increased radius of ventricle increases cardiac work
Increased work and O2 demand
CO falls
SNS outflow to increase HR and SVR
SV falls
What is cardiomyopathy?
Diseases of the myocardium associated with mechanical and/or electrical dysfunction with inappropriate hypertrophy or dilation
Cardiomyopathies are usually (acquired/genetic)
Genetic
Hypertrophic Cardiomyopathy
Asymmetric myocardial hypertrophy
There is obstruction of the ventricular outflow tract
- Asymmetric septal hypertrophy (superior aspect of the septum is hypertrophied and this interferes with valve function)
- Systolic anterior movement (SAM) of the mitral valve and resultant mitral regurgitation
There is diastolic dysfunction
Ischemia can occur
Dysrhythmias
Sudden death
S/S of hypertrophic cardiomyopathy
Angina Fatigue Syncope Tachydysrhythmias (SVT, a-fib) HF Sudden death (in young, healthy, undiagnosed patients)
Treatment of hypertrophic cardiomyopathy
Treat the underlying cause
BBs
CCBs
Factors that will worsen the outflow obstruction seen with hypertrophic cardiomyopathy
Tachycardia (this is usually how they die)
Hypovolemia (decreases preload)
Vasodilators (decreases preload and afterload)
Hypotension (decreases afterload)
PPV (decreases preload)
These factors IMPROVE outflow in hypertrophic cardiomyopathy
Decrease contractility: - Beta-adrengeric blockade - Volatile anesthetics - Calcium channel blockers Increase preload: - Hypervolemia - Bradycardia Increase afterload: - Hypertension - Alpha-adrenergic stimulation (phenylephrine)
What should you assume if your patient has a long-standing history of ETOH abuse?
They have dilated cardiomyopathy
What do the ventricles look like in dilated cardiomyopathy?
Large, dilated chambers with normal LV thickness